Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Buonocore, D., et al
SYNC Life works with individuals seeking a personalized, deeper approach to health especially those wanting to understand their unique biomarkers, improve lifestyle outcomes, and receive tailored treatment plans rather than general wellness advice
Some note only subtle improvements, and a few see no change at all
In 2022, the type 2 diabetes segment is dominating the largest market share over the forecast period
The Phase 2 program generated the key proof-of-concept data that propelled orforglipron into one of the largest Phase 3 development programs in metabolic disease
US$ 28.04
US$ 22.46
US$ 22.29
